ST
Healthcare & Life Sciences

SciBrunch Therapeutics

SciBrunch Therapeutics is a Healthcare & Life Sciences startup based in China, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
1
Investors

About SciBrunch Therapeutics

SciBrunch Therapeutics is a company headquartered in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

SciBrunch Therapeutics is a clinical-stage biotechnology company focused on the iterative innovation of small-molecule therapeutics targeting clinically validated oncology pathways, with an emphasis on hard-to-treat cancers such as pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).

Explore SciBrunch Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in China